These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Directed therapies in lung cancer: new hope?
    Author: Parente Lamelas I, Abal Arca J, Fírvida Pérez JL.
    Journal: Arch Bronconeumol; 2012 Oct; 48(10):367-71. PubMed ID: 22551924.
    Abstract:
    Lung cancer (LC) is a serious health problem due to its high incidence and mortality. Surgery is the most effective therapeutic strategy in this type of tumor, but in recent years new drugs are being investigated that target specific components of the tumor cells, improving survival in patients with advanced disease and relapse. We present a review of individualized treatments in LC, particularly therapies that inhibit epidermal growth factor receptor (EGFR), vascular endothelial growth factor (VEGF) and anaplastic lymphoma kinase (ALK).
    [Abstract] [Full Text] [Related] [New Search]